NAD+ 1G & TIRZEPATIDE'S SUCCESSOR : A UK NEWS

The recent interest in NAD+ supplementation, particularly at a significant dosage of one gram, continues to build within the British medical community. At the same time , attention is directed toward Retatrutide, a innovative GLP-1 analogue being viewed by many as a potential replacement to Tirze